Medical Oncology

Prof. Dr. Saadettin Kılıçkap

Doctor and researcher Liv Hospital Ankara Ankara
Lung NeoplasmsCarcinoma, Non-Small-Cell LungNeoplasmsBreast NeoplasmsColorectal NeoplasmsKidney NeoplasmsCarcinoma, Renal CellBrain NeoplasmsAdenocarcinomaSkin NeoplasmsStomach NeoplasmsPancreatic NeoplasmsMelanomaLiver NeoplasmsCarcinoma, Transitional CellBone NeoplasmsCarcinoma, Squamous CellUrinary Bladder NeoplasmsHodgkin DiseaseCarcinoma, HepatocellularUrologic NeoplasmsMesotheliomaPleural NeoplasmsOvarian NeoplasmsCOVID-19LymphomaRectal NeoplasmsThyroid NeoplasmsHepatitis BHepatitis CCarcinoma, Ovarian EpithelialColonic NeoplasmsBreast Neoplasms, MaleCentral Nervous System NeoplasmsNeuroendocrine TumorsPainGlioblastomaFatigueNeoplasms, Second PrimaryCarcinoma, Signet Ring CellCardiovascular DiseasesNeoplasms, Glandular and EpithelialVomitingPeritoneal NeoplasmsVirus DiseasesHypothyroidismCarcinomaLymphoma, Non-HodgkinNasopharyngeal NeoplasmsHeart Block
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

The CV details on this page were translated automatically from the language of the source. See the original

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lung Neoplasms 50 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Carcinoma, Non-Small-Cell Lung 37 publications
  • Neoplasms 35 publications
  • Breast Neoplasms 19 publications
  • Colorectal Neoplasms 13 publications
  • Kidney Neoplasms 12 publications
  • Carcinoma, Renal Cell 11 publications
  • Brain Neoplasms 10 publications
  • Adenocarcinoma 9 publications
  • Skin Neoplasms 8 publications
  • Stomach Neoplasms 8 publications
  • Pancreatic Neoplasms 7 publications
  • Melanoma 7 publications
  • Liver Neoplasms 7 publications
  • Carcinoma, Transitional Cell 6 publications
  • Bone Neoplasms 5 publications
  • Carcinoma, Squamous Cell 5 publications
  • Urinary Bladder Neoplasms 5 publications
  • Hodgkin Disease 4 publications
  • Carcinoma, Hepatocellular 4 publications
  • Urologic Neoplasms 4 publications
  • Mesothelioma 4 publications
  • Pleural Neoplasms 4 publications
  • Ovarian Neoplasms 4 publications
  • COVID-19 3 publications
  • Lymphoma 3 publications
  • Rectal Neoplasms 3 publications
  • Thyroid Neoplasms 3 publications
  • Hepatitis B 3 publications
  • Hepatitis C 2 publications
  • Carcinoma, Ovarian Epithelial 2 publications
  • Colonic Neoplasms 2 publications
  • Breast Neoplasms, Male 2 publications
  • Central Nervous System Neoplasms 2 publications
  • Neuroendocrine Tumors 2 publications
  • Pain 2 publications
  • Glioblastoma 2 publications
  • Fatigue 2 publications
  • Neoplasms, Second Primary 2 publications
  • Carcinoma, Signet Ring Cell 2 publications
  • Cardiovascular Diseases 2 publications
  • Neoplasms, Glandular and Epithelial 2 publications
  • Vomiting 2 publications
  • Peritoneal Neoplasms 2 publications
  • Virus Diseases 2 publications
  • Hypothyroidism 2 publications
  • Carcinoma 2 publications
  • Lymphoma, Non-Hodgkin 2 publications
  • Nasopharyngeal Neoplasms 2 publications
  • Heart Block 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

  • Medical oncology
  • Internal medicine
  • Cancer epidemiology
  • Lung cancer,
  • Melanoma, breast cancer,
  • Colorectal cancer, stomach cancer,
  • Gastrointestinal system cancers,
  • Sarcomas, genitourinary system cancers,
  • Head and neck tumors,
  • Glial tumors

CV

Education and experience

From source

Experience

  • Experience2016 – present Prof Dr. Hacettepe University Cancer Institute, Preventive Oncologylivhospital.com
  • Experience2012-2016 Associate Professor Hacettepe University Cancer Institute, Preventive Oncologylivhospital.com
  • Experience2010-2012 Associate Professor Cumhuriyet University Faculty of Medicine, Internal Medicinelivhospital.com
  • Experience2010 Assistant Professor Cumhuriyet University Faculty of Medicine, Internal Medicinelivhospital.com
  • Experience2009-2010 Specialist physician Cumhuriyet University Faculty of Medicine, Internal Medicinelivhospital.com
  • Experience2009 University of Regensburg, Hematology-Oncologylivhospital.com
  • Experience2003-2009 Specialist physician Hacettepe University Cancer Institute, Medical Oncologylivhospital.com
  • Experience1998-2003 Research assistant Dr. Hacettepe University Faculty of Medicine, Internal Medicinelivhospital.com

Education

  • Education2007-2009 Hacettepe University Cancer Institute, Cancer Epidemiology, Master’s degreelivhospital.com
  • Education2003-2007 Hacettepe University Cancer Institute, Medical Oncology Subspecialtylivhospital.com
  • Education1998-2003 Hacettepe University Faculty of Medicine, Internal Medicine, Specialty traininglivhospital.com
  • Education1992-1998 Gazi University Faculty of Medicinelivhospital.com

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Ankaralivhospital.comFrom source
  • Area of workLung NeoplasmsExtracted from 50 publications · Model version —From source
  • Publications479 publicationsOpenAlexFrom source
  • ORCID0000-0003-1637-7390ORCIDFrom source
  • Last synchronised4 November 2026 20:58https://www.livhospital.com/prof-dr-saadettin-kilickaplivhospital.com

Scientific work

Publications on Lung Neoplasms

479 publications

  1. Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

    Cancers, 2026

    DOI 10.3390/cancers18121979 PMID 42352512 Open-access full textSource: OpenAlex

  2. Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16868-5 Open-access full textSource: OpenAlex

  3. Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)

    Clinical & Translational Oncology, 2026

    DOI 10.1007/s12094-026-04494-3 PMID 42400766 Source: OpenAlex

  4. Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000604 PMID 41972337 Source: OpenAlex

  5. Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000610 PMID 42267536 Source: OpenAlex

  6. Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source: OpenAlex

  7. Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61177-3 PMID 42414499 Open-access full textSource: OpenAlex

  8. Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors

    JCO Global Oncology, 2026

    DOI 10.1200/go-25-00234 PMID 41855443 Open-access full textSource: OpenAlex

  9. Continued Cemiplimab Beyond Progression With Addition of Chemotherapy in Patients With Advanced NSCLC With PD-L1 Expression of 50% or Higher: 5-Year Follow-Up From EMPOWER-Lung 1

    JTO Clinical and Research Reports, 2026

    DOI 10.1016/j.jtocrr.2026.101029 PMID 42529322 Open-access full textSource: OpenAlex

  10. Investigating the feasibility of cascade genetic testing for BRCA1/2 in Türkiye: physicians' practices, barriers, and solutions

    European Journal of Cancer Care, 2026

    DOI 10.48130/ejcc-0026-0010 Source: OpenAlex

View all 479 publications